Comparing the effectiveness of four transdiagnostic among adults and adolescences
- Registration Number
- IRCT20231106059970N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 360
Age between 11-18 in adolescence sample
Age between 18 to 65 in adults group
Be able to read and speak Farsi fluently,
participant in in-person psychotherapy sessions
Adolescence sample meet full criteria for at least one emotional disorders
In Adult sample: meet full criteria for at least one emotional disorders and /or cluster B personality disorders
active suicidal plan
substance dependency,
meet criteria as schizophrenia and neurological diseases
psychiatry medicines
miss more than three psychotherapy session repeatedly
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Scores of Beck's Depression Inventory (BDI-II). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: Beck's Depression Inventory (BDI-II).;Scores of Beck's anxiety Inventory (BAI). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: Beck's anxiety Inventory (BAI).;Scores of the Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: The Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004).;Scores of the Positive and Negative Affect Schedule (PANAS). Timepoint: questionnaires will be assessed at baseline, post-treatment, 6,12,18,24 and 36-month follow-up. Method of measurement: The Positive and Negative Affect Schedule (PANAS) (Watson, Clark, & Tellegen, 1988).
- Secondary Outcome Measures
Name Time Method Scores of Shame severity. Timepoint: baseline, post- treatment, 6,12,18,24 and 36 months follow-up. Method of measurement: The Experience of Shame Scale (ESS, Andrews et al, 2002).